Daily Voice Hudson County NJ on MSN9 小时
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
来自MSN4 小时
These are the best at-home cold remedies, according to doctors
“Saline nasal spray can help with congestion and is safe if used according to the label,” said Ray. These sprays can help ...
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter ...
Men's Journal on MSN18 小时
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research ...
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
The New York Times21 小时
What Actually Helps When You Have a Cold or the Flu?
Relieving congestion: neti pots, herbs and steam Keeping your nasal passages moisturized is another simple, safe remedy that may help children and adults get some relief from the flu or cold.
Las Vegas Review-Journal8 小时
FDA proposes pulling decongestants from shelves over ingredient
Only a final order will affect what products can be marketed. Among the products containing oral phenylephrine as an active ...
abc7NY4 小时
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
Ban Lemsip because 'it doesn't work', say experts after US health chiefs propose pulling ...
Dozens of popular cold and flu remedies should be pulled from Britain's shelves because they don't work ... and science now ...
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...